Skip to main content
Csm Bradke header 498bf3128b

News categories: Honors & Funding

Frank Bradke receives the 50,000 Euro Academy Prize

Neurobiologist Frank Bradke, a research group leader at DZNE and professor at the University of Bonn, has been awarded the 50,000 euro Academy Prize of the Berlin-Brandenburg Academy of Sciences and Humanities. The award recognizes his outstanding scientific accomplishments in the field of neuronal development and regeneration. With his studies, the Bonn scientist, who focuses on fundamental mechanisms, aims to pave the way for a better treatment of spinal cord injuries. In recent years, Bradke has already been recognized with several awards for his exceptional research.

The nerve fibers in the spinal cord cannot regenerate. Thus, if they are damaged or even severed, this can result in permanent paralysis or have other serious outcomes. In light of this, Frank Bradke and his research team are investigating how neurons grow and whether it is possible to specifically activate this growth after neuronal damage. To this end, the Bonn researchers carry out studies on cell cultures as well as in mice and rats. Over the years they discovered, for example, how the cytoskeleton is involved in neuronal growth and also gained key insights into the mechanisms that prevent the regrowth respectively regeneration of neurons after damage.

“I am thrilled to receive this award. It is an extraordinary honor for me personally, but also a great recognition for the entire team from our lab. Because fundamental research, as we do it, is a team effort,” says Bradke.

The Academy Prize of the Berlin-Brandenburg Academy of Sciences and Humanities is awarded for outstanding scientific achievements in any disciplinary field and can be conferred every two years. On this occasion, it will be presented at a ceremony in Berlin on June 15.

Interview:

Also check out Frank Bradke's interview on spinal cord injuries

Press contact:

Dr. Markus Neitzert

E-Mail: markus.neitzert@dzne.de

Related news

News Icon

News categories: Honors & Funding

Acute lymphoblastic leukemia in children

Acute lymphoblastic leukemia (ALL) is the most common cancer in children and poses a significant threat to health. The joint research project "EDI-4-ALL" (Early detection and interception for acute lymphoblastic leukemia) aims at the development of new analysis tools for the early detection of a genetic predisposition to ALL in newborns. The project is a joint endeavour by leading scientists from the Universities of Düsseldorf, Gießen and Bonn, the Charité Berlin and Zytovision, under participation of Prof. Alksandra Pandyra. The project is funded with a total of 2.6 million Euros by the BMBF.
View entry
Cummings Center announcment group photo

News categories: Honors & Funding

Cooperation with the Cumming Global Centre

The Cumming Global Centre for Pandemic Therapeutics (Cumming Global Centre) and the University of Bonn have today announced Bonn-Cumming Host-Directed Pandemic Therapeutics Research Program (“the partnership”) to fund groundbreaking research into early immunity to develop novel targets for therapeutics for pathogens of pandemic potential. The funding volume amounts to 6 million euros, with a perspective of up to 40 million euros. A large part comes from the philanthropic billionaire Geoff Cumming.
View entry
Plastic bottles

News categories: Honors & Funding

Effects of “Forever Chemicals” on the Immune System

Dr. Lorenzo Bonaguro from the German Center of Neurodegenerative Dieseases (DZNE) has been awarded a Starting Grant from the European Research Council (ERC) totaling about 1.5 million euros to investigate the influence of the ubiquitous PFAS chemicals on the immune system. His research will utilize so-called organoids and cutting-edge analysis methods.
View entry

Back to the news overview